Abstract

COVID-19 crisis has posed newer challenges in cancer care with reports of disruption in treatment plans coming from across the world. Massive deluge of COVID-19 incidence in western countries along with the increased risk of fatal complications for active cancer patients made it difficult for cancer patients to maintain continuity of care. In India, a countrywide stringent lockdown has prevented a massive exposure to the population. Here we present a retrospective analysis of the impact of COVID-19 crisis on the deliberations of onco.com online multidisciplinary tumour boards in past 8 weeks.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call